Trulieve Cannabis Corp.
TRLV | NYSE
$11.10
+$0.82 (+7.98%)
Nov 2, 2026, 10:41 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 |
|---|---|---|---|---|---|
Net Income | -406.1M | 2.28M | -43.59M | -28.78M | -16.11M |
Depreciation & Amortization | 39.1M | 43.73M | 43.67M | 43.41M | 43.15M |
Stock-Based Compensation | 6.9M | 4.14M | 3.98M | 5.79M | 6.76M |
Other Working Capital | -700K | 23.47M | 50.67M | 56.37M | 60.67M |
Other Non-Cash Items | 412.2M | 2.92M | 7.43M | 6.34M | 11.03M |
Deferred Income Tax | -10.8M | -8.21M | -3.89M | -4.75M | -5.27M |
Change in Working Capital | 11.8M | 10.85M | 51.63M | 54.77M | 46.14M |
Operating Cash Flow | 53.1M | 55.71M | 59.22M | 76.77M | 85.7M |
Capital Expenditures | -21M | -13.48M | -6.99M | -16.51M | -16.22M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | -393K | 393K |
Other Investing Acitivies | -53.9M | 296K | -2.48M | -2.66M | 2.94M |
Investing Cash Flow | -74.9M | -13.19M | -5.89M | -15.38M | -8.24M |
Debt Repayment | -1.7M | 58.7M | -385.88M | -2.01M | -3.59M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4M | -3.87M | 130.49M | -2.76M | -2.24M |
Financial Cash Flow | -5.7M | 54.83M | -255.39M | -4.77M | -5.84M |
Net Cash Flow | -27.5M | 97.35M | -202.07M | 56.62M | 71.63M |
Free Cash Flow | 32.1M | 42.22M | 52.23M | 60.26M | 69.48M |
Adj. Free Cash Flow | 25.2M | 38.09M | 48.26M | 54.48M | 62.72M |
Maintenance CapEx | -21M | -13.48M | -6.99M | -16.51M | -16.22M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | 32.1M | 42.22M | 52.23M | 60.26M | 69.48M |
Add to Watchlist
Select watchlists to add or remove TRLV